How Much Did Freed Raise?
Funding & Key Investors

Freed, an AI medical scribe platform, has secured $30M in a major strategic investment, contributing to its total funding of $30M. This significant capital infusion underscores the growing enterprise-level interest in AI solutions designed to streamline clinical documentation and enhance physician efficiency. The recent financing round highlights the company's progress in addressing the critical need for advanced medical transcription and data structuring within electronic health record systems.

What is Freed?

Freed
SoftwareHealthcare Software

Freed operates as an AI-powered medical scribe, engineered to alleviate the administrative burden on clinicians. The platform intelligently transcribes patient visits, subsequently extracting, summarizing, and structuring medically relevant information. This process mirrors the function of a human scribe but without the associated training requirements, delivering formatted notes and additional documentation directly into a clinician's preferred EHR system. By automating these crucial documentation tasks, Freed aims to improve clinician satisfaction and allow for greater focus on patient care.

How much funding has Freed raised?

Freed has raised a total of $30M across 1 funding round:

2025

Series A

$30M

Series A (2025): $30M with participation from Sequoia Capital and Scale Venture Partners

Key Investors in Freed

Sequoia Capital

Sequoia Capital is a prominent venture capital firm with a long-term investment approach, known for backing early-stage to late-stage companies. Their expertise spans various sectors, and they actively partner with entrepreneurs to build market-leading businesses globally.

Scale Venture Partners

Scale Venture Partners is an early-stage venture capital firm that focuses on investing in founders building category-defining businesses, particularly in the AI space. They provide hands-on advisory services to support companies from initial growth to scalable operations.

What's next for Freed?

With this substantial enterprise-level funding, Freed is poised for accelerated growth and market expansion. The strategic investment suggests a focus on scaling operations, enhancing its AI capabilities, and potentially broadening its integration with a wider array of EHR systems. The company's trajectory indicates a move towards solidifying its position as a leader in the AI medical scribe market, further empowering healthcare providers by optimizing their documentation workflows and improving overall practice efficiency. Future developments will likely center on refining its core technology and expanding its user base within the healthcare sector.

See full Freed company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Financial SoftwareSoftware
SoftwareSupply Chain Management (SCM) SoftwareNetworking Software
Engineering SoftwareSoftwareAerospace & DefenseBusiness ServicesManufacturingResearch & Development
Security SoftwareSoftware

Frequently Asked Questions Regarding Freed Financial Insights

What are the most recent funding rounds that Freed has completed, and what were the funding rounds?
Freed has recently completed 1 funding rounds: Series A on Mar 5, 2025.
What is the total amount of funding Freed has raised to date?
Freed has raised a total of $30M in funding to date.
How many funding rounds has Freed completed?
Freed has completed 1 funding rounds.
How much funding did Freed raise in its most recent funding round?
Freed raised $30M in its most recent funding round.
Who are the lead investors in Freed's latest funding round?
The lead investor in Freed's latest funding round was Sequoia Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Freed's history?
The largest funding round in Freed's history was $30M.
See more information about Freed